Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Cigna GroupWBO:CIGN -0.83%24 3-Year FCF Growth Rate is 9.90% as of Jun. 2026, which is 10% below its 10-year median of 11.05. GuruFocus rates WBO:CIGN with a GF Score™ of 24/100 and a GF Value™ of €347.61 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 15 Healthcare Plans companies, The Cigna Group ranks better than 60% on this metric.
During the past 12 months, The Cigna Group's average Free Cash Flow per Share Growth Rate was 143.80% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 9.90% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 9.60% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 12.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of The Cigna Group was 173.10% per year. The lowest was -49.50% per year. And the median was 11.05% per year.
The Cigna Group (WBO:CIGN) 3-Year FCF Growth Rate Explanation
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
The Cigna Group 3-Year FCF Growth Rate Related Terms
WBO:CIGN vs ELV, HUM, CNC: 3-Year FCF Growth Rate Comparison
For the Healthcare Plans subindustry, The Cigna Group's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cigna Group 3-Year FCF Growth Rate vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, The Cigna Group's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where The Cigna Group's 3-Year FCF Growth Rate falls into.
The Cigna Group 3-Year FCF Growth Rate Calculation
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
The Cigna Group (WBO:CIGN) has a 3-Year FCF Growth Rate of 9.90% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for The Cigna Group and its competitors. This is 10% below median its historical median of 11.05. According to the industry distribution chart, The Cigna Group ranks #6 out of 15 companies in the Healthcare Plans industry, placing it in the top 40%.
Is The Cigna Group's 3-Year FCF Growth Rate too high?
The Cigna Group's current 3-Year FCF Growth Rate of 9.90% is 10% below median its 10-year median of 11.05. Based on the distribution chart, The Cigna Group ranks #6 out of 15 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, The Cigna Group has a GF Score™ of 24/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's 3-Year FCF Growth Rate compare to ELV and HUM?
According to the Healthcare Plans industry distribution chart, The Cigna Group ranks #6 out of 15 companies for 3-Year FCF Growth Rate. This puts The Cigna Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Healthcare Plans company?
A good 3-Year FCF Growth Rate depends on the Healthcare Plans industry context. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for The Cigna Group and its competitors. The Cigna Group's current 3-Year FCF Growth Rate is 9.90%, which is 10% below median its own 10-year median of 11.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (WBO:CIGN) is currently considered Significantly Undervalued. The stock's GF Value™ is €347.61, compared to a current price of €239.50 — trading 31.1% below its estimated fair value. The current 3-Year FCF Growth Rate is 9.90%, which is 10% below median its 10-year median of 11.05. The Cigna Group's overall GF Score™ is 24/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For The Cigna Group (WBO:CIGN), the current 3-Year FCF Growth Rate is 9.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cigna Group (WBO:CIGN) Overvalued in 2026?
Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued.
The current stock price of €239.50 is trading 31.1% below its estimated GF Value™ of €347.61.
GuruFocus considers The Cigna Group to be Significantly Undervalued.
Key valuation signals for WBO:CIGN:
3-Year FCF Growth Rate: 9.90% (10% below median its 10-year median of 11.05)
GF Value™: €347.61 vs. price of €239.50 (31.1% below fair value)
No single metric tells the full story. See the WBO:CIGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
24GF Score
Get the complete analysis for WBO:CIGN
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:CIGN has been successfully added to your 
